What is the difference between Argireline and SNAP-8?

Argireline: Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects SNAP-8: Octapeptide extension of Argireline; competes with SNAP-25 for SNARE complex binding; reduces muscle contraction at neuromuscular junction

Is Argireline FDA approved?

Argireline is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is SNAP-8 FDA approved?

SNAP-8 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Argireline administered in research settings?

In research settings, Argireline is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

How is SNAP-8 administered in research settings?

In research settings, SNAP-8 is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Argireline vs SNAP-8

Peptide Comparison

Argireline vs SNAP-8

Name: Argireline vs SNAP-8 — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Skin & Cosmetic peptides.

Argireline

Acetyl Hexapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full Argireline profile →

SNAP-8

Acetyl Octapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full SNAP-8 profile →

Bottom line

Argireline has published research citations on file; SNAP-8 does not yet — the main evidence gap between them.

Quick Verdict

Argireline

Evidence

Clinical

SNAP-8

Evidence

Not rated

Which One Should You Choose?

Your goal	Better option
Has published research citations	Argireline

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Argireline

SNAP-8

Mechanism Family

Skin & Cosmetic

Half-life

N/A (topical)

FDA Status

not evaluated

Admin Routes

topical

Availability

Research Only

Providers

18 listed

Avail. Notes

Cosmetic peptide (acetyl hexapeptide-3). Sold as cosmetic ingredient by Lipotec/Sederma. Not regulated as a drug by FDA. No NDA or IND. Cosmetic anti-wrinkle ingredient only.

Cosmetic peptide (acetyl octapeptide-3). SNAP-25 analog sold as topical anti-wrinkle cosmetic ingredient. Not regulated as a drug by FDA. No NDA or IND. Cosmetic use only.

Research Evidence

Argireline

ClinicalRCT · 3 key studies · most recent 2026

SNAP-8

No citations on file

Research Citations

Argireline

RCT2013 · American Journal of Clinical Dermatology

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-…

Cohort2026 · Biomater Adv

DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging.

RCT2017 · Journal of Cosmetic Dermatology

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3: a prospective, ra…

SNAP-8

No citations on file.

About Argireline

Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects

Research Areas

SNARE complex (SNAP-25) competitive inhibition reducing expression line depthwrinkle reduction documented in controlled human trialstopical cosmetic application — not a systemic peptidesoftening of dynamic lines over 4–8 weeks at 5–10% concentration

About SNAP-8

Octapeptide extension of Argireline; competes with SNAP-25 for SNARE complex binding; reduces muscle contraction at neuromuscular junction

Research Areas

expression line reductionwrinkle depth decreaseanti-aging skin

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Argireline

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

SNAP-8

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Argireline

Not enough vendor pricing yet.

SNAP-8

$3.50/mg

$3.15 – $3.90 range

10 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Argireline

18 listed

Browse directory →

Providers offering

SNAP-8

18 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Argireline vs SNAP-8 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/argireline/snap-8

https://peptidebase.io/peptides/compare/argireline/snap-8 Methodology License Download JSON Download CSV